Cancer risks of insulin therapy

Lapis Light patients know that insulin resistance is a risk factor for numerous cancers and that insulin is elevated in metabolic syndrome years before diabetes sets in. This study documents that insulin therapy given in the treatment of type 2 diabetes increases the likelihood of developing a range of solid tumors, highlighting the action of insulin as a proliferating hormone. Obviously this must be taken into consideration in diabetes case management and prevention.